General Info
Taisho Pharmaceutical Holdings is a pharmaceutical company that provides medical drugs for patients.
Location: Tokyo
Country:
Industries:
Investment Regions: SEA
Investment Stages:
corporate-vc
SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Searches of Taisho Pharmaceutical Holdings news and corporate releases show the most recent external collaboration/license announcements were in 2021 (Biolinq, Ancora Bio) and corporate/structural notices in 2023-2024 (MBO and restructuring). I found no evidence of investments or deals involving Taisho Pharmaceutical Holdings or its venture arm in the 12 months prior to the reference date. The most recent identified startup collaboration was with Biolinq (2021). Based on the span since the last known investment/collaboration (over 12 months), the appropriate classification is ‘not-active.’
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Taisho Pharmaceutical Holdings
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI